Business StandardCenter·
Biocon share price rises 3% after block deal, Pertuzumab deal in Brazil
According to data compiled by Bloomberg, around 16.6 million shares of Biocon changed hands on the BSE in a single pre-market block trade.
Read at Business Standard →

